MEA Diagnostic and Monitoring Devices Market Size and Forecast by Offering, Technology, Clinical Application, Distribution Channel, and End User: 2019-2033

---

Industry Assessment Overview

Industry Findings: Regional commitments to local production and diagnostics capacity are changing procurement logic across Africa and the Middle East — the WHO African Region’s strategy and continental manufacturing push have created a two-track demand profile: large public purchasers still buy centralized, high-throughput platforms while national programmes and donors prioritise locally manufacturable, low-cost POC and reagent lines. The WHO AFRO regional diagnostic strategy (Jul-2023) and AU manufacturing commitments are pushing governments to favour suppliers that can support local production, quality systems and multi-country logistics.

Industry Progression: Progress is visible where policy meets procurement: Africa CDC and partners published a prioritized diagnostics list and mobilised technical support for priority tests (Dec-2024), enabling pooled procurement pilots and targeted donor funding for laboratory upgrades. The action has begun to convert regional strategy into ordered kits and reagents, shortening lead times for priority assays in participating countries and increasing demand for vendors who can scale manufacturing or supply chain support quickly.

Industry Player Insights: Prominent companies shaping the region’s competitive tone include Roche Diagnostics, Siemens Healthineers, GE HealthCare, and Revital Healthcare etc. The vendor mix reflects global scale plus emergent local capacity: Roche and Siemens continue to land multi-country tenders for centralized analyzers, GE supplies imaging and monitoring bundles, while Revital Healthcare’s May-2025 local manufacturing updates (May-2025) demonstrate growing domestic supply options — together these choices reduce single-supplier risk and support sustainable reagent flows.